Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
71,733.18
(
-1.84%
)
News Focus
News Focus
Post# of 257390
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 224877

Friday, 05/17/2019 9:46:09 PM

Friday, May 17, 2019 9:46:09 PM

Post# of 257390

(ASMB)—ENTA’s CEO, Jay Luly just said that ASMB’s HBV core inhibitor is probably too weak, based on data presented at EASL (in so many words).

Judging by ASMB's own actions via the development of much more potent follow-on versions, I'd say they likely agree. ; )
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today